Literature DB >> 23488973

The importance of pro-inflammatory and anti-inflammatory cytokines in Pneumocystis jirovecii pneumonia.

Chung-Wei Chou1, Fang-Chi Lin, Han-Chen Tsai, Shi-Chuan Chang.   

Abstract

The role of pro-inflammatory and anti-inflammatory cytokines in Pneumocystis jirovecii pneumonia (PcP) of non-AIDS immunocompromised patients remains unclear. We measured the levels of pro-inflammatory cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and anti-inflammatory cytokines including IL-10 and transforming growth factor (TGF)-β1 in bronchoalveolar lavage fluid (BALF) and blood in 36 non-AIDS immunocompromised patients with PcP diagnosed by BAL and explored their clinical importance. The severity of PcP was determined by arterial oxygen tension/fraction of inspired oxygen concentration (PaO2/FiO2) ratio, the need of mechanical ventilation and the death. Twenty-five subjects without evidence of lung abnormality were included as control group. Compared with control group, PcP patients had significantly higher BALF levels of IL-1β, TNF-α, IL-6, IL-8 and MCP-1 and significantly higher blood levels of IL-10, TGF-β1, IL-8, IL-6 and MCP-1. For PcP patients, BALF levels of IL-8, IL-8/IL-10 ratio and IL-8/TGF-β1 ratio and blood levels of IL-8 and IL-8/IL-10 ratio were significantly higher in the patients with PaO2/FiO2 < 200 mmHg than in those with PaO2/FiO2 > 200 mmHg. Similarly, significantly higher BALF levels of IL-8, IL-8/IL-10 ratio, IL-1β/IL-10, IL-1β/TGF-β1 ratio, MCP-1/TGF-β1 ratio and IL-8/TGF-β1 ratio were found in the patients requiring mechanical ventilation and in non-survivors. In summary, an imbalance of pro-inflammatory and anti-inflammatory cytokines in BALF was found in PcP of non-AIDS immunocompromised patients. BALF levels of IL-8, IL-8/IL-10 ratio, IL-1β/IL-10 ratio, IL-1β/TGF-β1 ratio, MCP-1/TGF-β1 ratio and IL-8/TGF-β1 ratio may be of value in assessing the severity of PcP and in predicting the outcome of the patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23488973     DOI: 10.3109/13693786.2013.772689

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  13 in total

Review 1.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

2.  Characterization of chemokine and chemokine receptor expression during Pneumocystis infection in healthy and immunodeficient mice.

Authors:  Lisa R Bishop; Michail S Lionakis; Monica Sassi; Philip M Murphy; Xiaojun Hu; Da Wei Huang; Brad Sherman; Ju Qiu; Jun Yang; Richard A Lempicki; Joseph A Kovacs
Journal:  Microbes Infect       Date:  2015-06-05       Impact factor: 2.700

Review 3.  Pneumocystis jirovecii-associated immune reconstitution inflammatory syndrome-like phenomenon in a child with leukaemia: a case report and literature review.

Authors:  Jia-Ying Lei; Han Chen; Dun-Hua Zhou; Lu-Hong Xu; Jian-Pei Fang; You-Gang Mai
Journal:  BMC Pediatr       Date:  2022-07-12       Impact factor: 2.567

4.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

5.  MUC1 mediates Pneumocystis murina binding to airway epithelial cells.

Authors:  Yueqin Liu; A Sally Davis; Liang Ma; Lisa Bishop; Ousmane H Cissé; Geetha Kutty; Joseph A Kovacs
Journal:  Cell Microbiol       Date:  2020-02-19       Impact factor: 4.115

6.  The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.

Authors:  Chung-Wei Chou; Fang-Chi Lin; Han-Chen Tsai; Shi-Chuan Chang
Journal:  BMC Pulm Med       Date:  2014-11-19       Impact factor: 3.317

7.  Clinical Usefulness of Urinary Fatty Acid Binding Proteins in Assessing the Severity and Predicting Treatment Response of Pneumonia in Critically Ill Patients: A Cross-Sectional Study.

Authors:  Tsung-Cheng Tsao; Han-Chen Tsai; Shi-Chuan Chang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study.

Authors:  Chung-Wei Chou; Heng-Sheng Chao; Fang-Chi Lin; Han-Chen Tsai; Wei-Hsin Yuan; Shi-Chuan Chang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

9.  Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study.

Authors:  Stefano Aliberti; Letizia Corinna Morlacchi; Paola Faverio; Rafael Fernandez-Botran; Roberto Cosentini; Marco Mantero; Paula Peyrani; Julio Ramirez; Jose Bordon; Francesco Blasi
Journal:  Pneumonia (Nathan)       Date:  2016-06-23

10.  Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.

Authors:  Jia Sun; Junwei Su; Yirui Xie; Michael T Yin; Ying Huang; Lijun Xu; Qihui Zhou; Biao Zhu
Journal:  J Immunol Res       Date:  2016-08-07       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.